Alphabet may be the Dow's newest member, but these three dividend-paying Dow stocks look like the better buys for income ...
Over 900,000 bottles of heart and kidney medications are being recalled from retailers nationwide due to possible ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Testing that raised concerns about possible foreign contamination has triggered a recall in the United States of nearly 1 ...
A U.S. Centers for Medicare & Medicaid Services 18-month trial program will offer for the first time Novo Nordisk’s Wegovy ...
Roche’s investigational KRAS G12C inhibitor has beaten Amgen’s Lumakras and Bristol Myers Squibb’s Krazati in a phase 3 trial ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
A federal judge on Wednesday blocked Colorado from capping the price of Amgen's blockbuster arthritis drug Enbrel, a first ...
If your medication is affected, ask your healthcare provider how to proceed.
Amgen recalls 934K bottles of Corlanor and Sensipar due to foreign material and manufacturing deviations, per FDA June 23 report.
This further weakens Amgen’s case for Tavneos’ continued use on the market as the drug comes under intense regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results